GEISTLICH PHARMA AG
34Patents
33Active
34Granted
53Portfolio score
Filing activity: Mar 8, 2004 → Jan 9, 2023 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| USD721803S1 | Syringe | General | 83 | Active |
| US9066995B2 | Bone substitute material | Human Necessities | 7 | Active |
| US8734524B2 | Bone substitute material | Performing Operations; Transporting | 7 | Active |
| US9844555B2 | Oxathiazine derivatives as antibacterial and anticancer agents | Emerging Cross-Sectional Technologies | 4 | Active |
| US8491592B2 | Device for the application of bone substitute material | Human Necessities | 4 | Active |
| US9241943B2 | Oxathiazine derivatives as antibacterial and anticancer agents | Emerging Cross-Sectional Technologies | 4 | Active |
| US10835640B2 | Resorbable crosslinked form stable membrane for use outside the oral cavity | Human Necessities | 3 | Active |
| US9624187B2 | Oxathiazine derivatives as antibacterial and anticancer agents | Emerging Cross-Sectional Technologies | 3 | Active |
| US10392355B2 | Processes for preparing oxathiazin-like compounds | Chemistry; Metallurgy | 2 | Active |
| US7479505B2 | Use of taurolidine to treat tumors | Human Necessities | 2 | Expired |
| US10968190B2 | Processes for preparing oxathiazin-like compounds | Chemistry; Metallurgy | 2 | Active |
| US10736902B2 | Method of treating triple negative breast cancer | Human Necessities | 2 | Active |
| US10300171B2 | Resorbable crosslinked form stable membrane | Human Necessities | 1 | Active |
| US10695461B2 | Dried implant composition and injectable aqueous implant formulation | Human Necessities | 1 | Active |
| US10869949B2 | Method for treating subjects suffering from chronic ulcers | Human Necessities | 1 | Active |
| US11591302B2 | Processes for preparing oxathiazin-like compounds | Chemistry; Metallurgy | 1 | Active |
| US10646615B2 | Bone substitute material | Performing Operations; Transporting | 1 | Active |
| US8852580B2 | Method and device for synovial cell-charged collagen membrane or gel | Emerging Cross-Sectional Technologies | 0 | Active |
| US10029028B2 | Biomimetic collagen-hydroxyapatite composite material | Human Necessities | 0 | Active |
| USRE48536E1 | Collagen sponge | General | 0 | Active |
| US9770538B2 | Method and membrane for skin regeneration | Human Necessities | 0 | Active |
| US8852617B2 | Antimicrobial dental care preparation | Human Necessities | 0 | Active |
| US10960107B2 | Collagen matrix or granulate blend of bone substitute material | Human Necessities | 0 | Active |
| US10646619B2 | Bone substitute material | Human Necessities | 0 | Active |
| US11571494B2 | Method for treating subjects suffering from chronic ulcers | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.